Biogen lifts annual profit forecast as new treatments boost earnings
Go back to Biogen lifts annual profit forecast as new treatments boost earnings| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 214.02 -6.81 (3.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $220.83 | 52 Week High | $333.65 | |||
| Open | $215.45 | 52 Week Low | $223.02 | |||
| Day High | $217.28 | P/E | 27.40 | |||
| Day Low | $210.54 | EPS | $7.81 | |||
| Volume | 307,468 | |||||

